Nanobiotix is trading 5.14% up at $29.55 on November 3, 2026, with no company-specific catalyst identified for the rise. - A reported biotech-sector rally, with XBI up 2.13% amid rotation out of technology, offers sector context rather than a company-specific explanation. - The latest company news surfaced in search was the October 24 Phase 1 melanoma data release, not a November 3 catalyst. - The price fell sharply on November 2 before rebounding; no volume information was provided.